Report of Nation-wide Questionnaire Survey for Abdominal Aortic Aneurysm Treatment in Korea.
- Author:
Young Wook KIM
1
;
Seung Kee MIN
;
Yong Bok KOH
;
Seung Nam KIM
;
Jang Sang PARK
;
In Sung MOON
;
Sang Woo PARK
;
Seung HUH
;
Jun Young CHOI
;
Hochul PARK
;
Won Hyun CHO
;
Hyoung Tae KIM
;
Ki Hyuk PARK
;
Jung Ahn RHEE
;
Kwang Jo CHO
;
Sung Woon CHUNG
;
Yong Shin KIM
;
Dong Ik KIM
;
Young Soo DO
;
Sang Joon KIM
;
Jongwon HA
;
Jae Hyung PARK
;
Hyuk AHN
;
Taeseung LEE
;
Joong Haeng CHOH
;
Doosang KIM
;
Won Heum SHIM
;
Do Yun LEE
;
Koing Bo KWUN
;
Bo Yang SUH
;
Woo Hyung KWUN
;
Yong Pil CHO
;
Geun Eun KIM
;
Tae Won KWON
;
Hong Rae CHO
;
Byung Jun SO
;
Hee Jae JUN
;
Shin Kon KIM
;
Sang Young CHUNG
;
Soo Jin Na CHOI
;
Sung Hwan KIM
;
Jeong Hwan CHANG
;
Lee Chan JANG
;
In Gyu KIM
;
Hyun Chul KIM
Author Information
- Publication Type:Multicenter Study ; Original Article
- Keywords: Aortic aneurysm; Treatment outcome; Questionnaire
- MeSH: Aneurysm; Aortic Aneurysm; Aortic Aneurysm, Abdominal*; Blood Vessel Prosthesis; Endoleak; Humans; Korea*; Mortality; Questionnaires*; Rupture; Treatment Outcome
- From:Journal of the Korean Society for Vascular Surgery 2005;21(1):10-15
- CountryRepublic of Korea
- Language:Korean
- Abstract: While endovascular aneurysm repair (EVAR) is prevailing for the treatment of abdominal aortic aneurysm (AAA) in modern vascular practice, PURPOSE: we conducted nationwide questionnaire survey to investigate the current status of AAA treatment and their results in Korea. METHOD: We reviewed the replies from 28 hospitals (33 departments) to the questionnaire inquiring annual number, clinical features, mode of treatment and results of AAA patients during the period from Jan. 2000 to Jul. 2004. Results: 980 AAA patients were reported including 292 ruptured AAA (29.8%) and 688 non-ruptured AAA (70.2%). For treatment of AAA, 834 (85.1%) surgical repairs (SRs) and 111 (11.3%) endovascualr aneurysm repairs (EVARs) were performed while 35 patients (3.6%) died of AAA rupture before operation. The locations of AAA were infrarenal in 889 (90.7%), juxtarenal in 62 (6.3%), and suprarenal in 29 patients (3.0%). Among 834 patients undergoing SR, 577 patients (69.2%) had non-ruptured AAAs and 257 patients (30.8%) had ruptured AAAs. Mean operative mortality rate was 4.1% after elective SRs, 30.7% after SR for ruptured AAAs, and 2.3% after EVARs. The reported brand name of stent graft devices were various including domestic custom-made in 56 (50.5%), imported brand in 18 (16.2%) while 37 (33.3%) stent grafts were not reported their brand name. The frequencies of type I and III endoleaks after EVAR were reported 5.8% and 5.8% respectively in 86 patients with an available data. CONCLUSION: SR has been used as a major treatment option in Korea for the treatment of AAA patients while EVAR is increasing. The mortality rate of SR of AAA was comparable to western multi-center trial reports but mortality or morbidity rates of EVAR were unable to know in this questionnaire survey.
